The SpicyIP Blog notes that Canada is one of several countries that have asked to join consultations on the World Trade Organization dispute between India and the EU over in-transit seizures of generic medicines (ie. seizures of the meds originating in India and traveling through Europe to another destination).  The request notes:

Canada has a substantial trade interest in these consultations, as it exports 40% of generic drugs manufactured in Canada to over 120 countries. Canada is also an active WTO Member on the issue of public health, including access to medicines. Accordingly, Canada requests to join in these consultations.

Other countries seeking to join the consultations include Japan (another ACTA participant), Ecuador, Brazil, China, and Turkey.